BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Nectar Lifescience Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
532649
ISIN Demat
INE023H01027
Book Value (Rs)
36.7483544
NSE Symbol
NECLIFE
Divident Yield %
0
Market Cap
(Rs In Cr.)
280
P/E (TTM)
0
EPS (TTM)
0
Face Value
(Rs)
1
Back
Nectar Lifescience consolidated net profit rises 82.02% in the December 2025 quarter
24-Jan-26   Hrs IST

Net profit of Nectar Lifescience rose 82.02% to Rs 14.27 crore in the quarter ended December 2025 as against Rs 7.84 crore during the previous quarter ended December 2024. There were no Sales reported in the quarter ended December 2025 and during the previous quarter ended December 2024.

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)